Contralateral Primary Tumors in Breast Cancer Patients in a Randomized Trial of Adjuvant Tamoxifen Therapy

Prophylactic treatment with the anti-estrogen tamoxifen may reduce the risk of breast cancer because estrogens are thought to act as promotors in the pathogenesis of the disease. This article presents results on the incidence of contralateral new primary tumors among 1846 postmenopausal breast cance...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JNCI : Journal of the National Cancer Institute 1991-09, Vol.83 (18), p.1299-1306
Hauptverfasser:	Rutqvist, Lars E., Cedermark, Björn, Glas, Ulla, Mattsson, Anders, Skoog, Lambert, Somell, Anders, Theve, Tolle, Wilking, Nils, Askergren, Jutta, Hjalmar, Marie-Louise, Rotstein, Sam, Perbeck, Leif, Ringborg, Ulrik
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biological and medical sciences Breast Neoplasms - chemistry Breast Neoplasms - epidemiology Breast Neoplasms - prevention & control Female Follow-Up Studies Humans Incidence Medical sciences Middle Aged Neoplasms, Multiple Primary - chemistry Neoplasms, Multiple Primary - epidemiology Neoplasms, Multiple Primary - prevention & control Neuropharmacology Odds Ratio Pharmacology. Drug treatments Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Receptors, Estrogen - drug effects Receptors, Progesterone - drug effects Survival Rate Tamoxifen - therapeutic use Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!